Cyclo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 48.5%.

Top 25 shareholders own 52.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
31.5%	Rafael Holdings, Inc.	9,029,940	US$6.5m	0%	no data
5.23%	Armistice Capital LLC	1,501,625	US$1.1m	0%	0.03%
2.85%	EPIQ Capital Group, LLC	817,270	US$589.7k	-4.28%	0.2%
2.59%	N. Fine	743,804	US$536.7k	0%	no data
2.06%	The Founders Fund, LLC	590,731	US$426.3k	0%	0.56%
1.56%	The Vanguard Group, Inc.	446,573	US$322.2k	12.6%	no data
1.22%	F. Ostronic	348,771	US$251.7k	3.18%	no data
1.21%	Markus Sieger	347,100	US$250.5k	5.58%	no data
1.06%	C. Strattan	305,495	US$220.4k	3.22%	no data
0.61%	Geode Capital Management, LLC	175,418	US$126.6k	9.81%	no data
0.47%	William Shanahan	133,681	US$96.5k	6.31%	no data
0.44%	Randall Toig	125,759	US$90.7k	9.13%	no data
0.32%	Jeffrey Tate	92,042	US$66.4k	0%	no data
0.32%	Shawn Cross	90,521	US$65.3k	11.1%	no data
0.21%	BlackRock, Inc.	59,510	US$42.9k	60.3%	no data
0.14%	State Street Global Advisors, Inc.	39,530	US$28.5k	0%	no data
0.12%	William Conkling	33,570	US$24.2k	35.2%	no data
0.086%	Citadel Advisors LLC	24,670	US$17.8k	0%	no data
0.086%	Vivien Wong	24,568	US$17.7k	47.7%	no data
0.082%	Wealth Enhancement Advisory Services, LLC	23,400	US$16.9k	14.7%	no data
0.076%	Northern Trust Global Investments	21,722	US$15.7k	-0.09%	no data
0.059%	Joshua Fine	16,900	US$12.2k	0%	no data
0.047%	Renaissance Technologies LLC	13,356	US$9.6k	-38.6%	no data
0.043%	Michael Lisjak	12,400	US$8.9k	0%	no data
0.042%	UBS Asset Management AG	12,053	US$8.7k	150%	no data